41 related articles for article (PubMed ID: 27192528)
1. Dual NAMPT and BTK Targeting Leads to Synergistic Killing of Waldenström Macroglobulinemia Cells Regardless of MYD88 and CXCR4 Somatic Mutation Status.
Cea M; Cagnetta A; Acharya C; Acharya P; Tai YT; Yang C; Lovera D; Soncini D; Miglino M; Fraternali-Orcioni G; Mastracci L; Nencioni A; Montecucco F; Monacelli F; Ballestrero A; Hideshima T; Chauhan D; Gobbi M; Lemoli RM; Munshi N; Treon SP; Anderson KC
Clin Cancer Res; 2016 Dec; 22(24):6099-6109. PubMed ID: 27287071
[TBL] [Abstract][Full Text] [Related]
2. Extramedullary Waldenström Macroglobulinemia Presenting as a Subcutaneous Penile Mass.
Palmer CJ; Sahagun J; David AG; Taylor CW; Al-Shraideh Y
Cureus; 2021 Sep; 13(9):e17809. PubMed ID: 34660019
[TBL] [Abstract][Full Text] [Related]
3. Occurrence of acute monocytic leukemia in a case of untreated Waldenström's macroglobulinemia.
Murashige N; Tabanda R; Zalusky R
Am J Hematol; 2002 Oct; 71(2):94-7. PubMed ID: 12353307
[TBL] [Abstract][Full Text] [Related]
4. Penile ulcer as a specific clinical manifestation of Waldenstrom's macroglobulinemia.
Oliveira CC; Bressa JA; Mendes F; Roncada EV; Monteiro R; Abreu MA
An Bras Dermatol; 2016 Apr; 91(2):236-8. PubMed ID: 27192528
[TBL] [Abstract][Full Text] [Related]
5. [Cutaneous Waldenström's macroglobulinemia].
Mantoux F; Castanet J; Perrin C; Fuzibet JG; Lacour JP; Ortonne JP
Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):53-5. PubMed ID: 11937931
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous Waldenström's macroglobulinemia. A report of a case successfully treated with radiotherapy.
Orengo IF; Kettler AH; Bruce S; Levy ML; Rosen T; Tschen J
Cancer; 1987 Sep; 60(6):1341-5. PubMed ID: 3113711
[TBL] [Abstract][Full Text] [Related]
7. [Ulceronecrotic purpura revealing Waldenström's macroglobulinemia].
Retornaz F; Monestier S; Richard MA; Seux V; Grob JJ; Soubeyrand J
Presse Med; 2001 Jun; 30(20):1007. PubMed ID: 11433686
[No Abstract] [Full Text] [Related]
8. Deposits of paraprotein in small vessels as a cause of skin ulcers in Waldenström's macroglobulinemia.
Wagner DR; Eckert F; Gresser U; Landthaler M; Middeke M; Zöllner N
Clin Investig; 1993 Dec; 72(1):46-9. PubMed ID: 8136617
[TBL] [Abstract][Full Text] [Related]
9. Assessment of bone marrow response in Waldenström's macroglobulinemia.
Varghese AM; Rawstron AC; Ashcroft AJ; Moreton P; Owen RG
Clin Lymphoma Myeloma; 2009 Mar; 9(1):53-5. PubMed ID: 19362973
[TBL] [Abstract][Full Text] [Related]
10. Overview of monoclonal gammopathies of undetermined significance.
Vogt RF; Marti GE
Br J Haematol; 2007 Dec; 139(5):687-9. PubMed ID: 18021082
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in symptomatic Waldenstrom's macroglobulinemia.
Merlini G; Baldini L; Broglia C; Comelli M; Goldaniga M; Palladini G; Deliliers GL; Gobbi PG
Semin Oncol; 2003 Apr; 30(2):211-5. PubMed ID: 12720138
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous Waldenström's macroglobulinemia: report of a case and overview of the spectrum of cutaneous disease.
Libow LF; Mawhinney JP; Bessinger GT
J Am Acad Dermatol; 2001 Dec; 45(6 Suppl):S202-6. PubMed ID: 11712059
[TBL] [Abstract][Full Text] [Related]
13. Waldenstrom's macroglobulinemia.
Dimopoulos MA; Alexanian R
Blood; 1994 Mar; 83(6):1452-9. PubMed ID: 8123836
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
